CCL5

CCL5 Informations sur la molécule

Nom anglais	C-C motif chemokine 5	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	2	Alias de la cible	Beta-Chemokine RANTES，Regulated Upon Activation， Normally T-Expressed， And Presumably Secreted，RANTES，TCP228，SIS-Delta，SISd，Small-Inducible Cytokine A5，D17S136E，T Cell-Specific Protein P228，EoCP，C-C Motif Chemokine 5，C-C Motif Chemokine Ligand 5，CCL5，Small Inducible Cytokine A5 (RANTES)，Chemokine (C-C Motif) Ligand 5，T-Cell Specific RANTES Protein，T-Cell Specific Protein P288，Small Inducible Cytokine Subfamily A (Cys-Cys)， Member 5，Eosinophil Chemotactic Cytokine，T-Cell-Specific Protein RANTES，SCYA5，Chemokine CXCL5，MGC17164
Phase de R&D la plus avancée	Phase 2 Clinical

Nom anglais	C-C motif chemokine 5
Alias de la cible	Beta-Chemokine RANTES，Regulated Upon Activation， Normally T-Expressed， And Presumably Secreted，RANTES，TCP228，SIS-Delta，SISd，Small-Inducible Cytokine A5，D17S136E，T Cell-Specific Protein P228，EoCP，C-C Motif Chemokine 5，C-C Motif Chemokine Ligand 5，CCL5，Small Inducible Cytokine A5 (RANTES)，Chemokine (C-C Motif) Ligand 5，T-Cell Specific RANTES Protein，T-Cell Specific Protein P288，Small Inducible Cytokine Subfamily A (Cys-Cys)， Member 5，Eosinophil Chemotactic Cytokine，T-Cell-Specific Protein RANTES，SCYA5，Chemokine CXCL5，MGC17164
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	2
Phase de R&D la plus avancée	Phase 2 Clinical

CCL5 Liste de produits

Attribut
Protein (2)Kits (1)
Bibliothèque de produits
En ligne (3)
Espèces
Human (3)
Étiquette
Fc Tag (1)- (1)Tag Free (1)
Marqueur
Unconjugated (2)- (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Pré-commande/Commande
CC5-H5113	Human	E. coli	Human CCL5/RANTES Protein, Tag Free	Ajouter au panier
CC5-H5251	Human	HEK293	Human CCL5/RANTES Protein, Fc Tag (MALS verified)	Ajouter au panier
CEA-C088	Human	-	Human CCL5/RANTES ELISA Kit	Ajouter au panier

Quantité totale3

CCL5Contexte de la molécule

C-C chemokine ligand 5 (CCL5), also known as RANTES, is a target gene of NF-kappaB, and is expressed by T lymphocytes, macrophages, platelets, synovial fibroblasts, tubular epithelium, and certain types of tumour cells. CCL5 plays a role in recruiting a variety of leukocytes into inflammatory sites including T cells, macrophages, eosinophils, and basophils. CCL5 activity is mediated through its binding to CCR1, CCR3, and mainly CCR5.

CCL5Alias de la molécule

EoCP,Eosinophil chemotactic cytokine,SIS-delta,Small-inducible cytokine A5,T cell-specific protein P228,TCP228,D17S136E, SCYA5,CCL5,C-C motif chemokine 5 T-cell-specific protein RANTES

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
AFX-5931	AFX-5931	Phase 2 Clinical	Afecta Pharmaceuticals Inc	Eczema	Details
MW-151	MW01-9-034WH; MW-151; MW01-2-151SRM	Phase 1 Clinical	University Of Kentucky	Drug-Related Side Effects and Adverse Reactions; Poisoning	Details